Dr Claudia Allemani
MSc PhD FHEA MFPH
of Cancer Epidemiology
Dr Claudia Allemani’s background covers the range from applied mathematics to public health and education, via epidemiology and medical statistics. She graduated in mathematics from the University of Turin (Italy) in 1996, then completed a Masters in Statistical and Informatic Methods for data analysis in the University of Milan (Italy) in 1998, followed by a specializzazione [PhD equivalent] in Medical Statistics in 2001 and a PhD in Public Health and Education in 2006, both in the University of Pavia (Italy). She was elected a Fellow of the Higher Education Academy in July 2012. She became an Honorary Member of the UK Faculty of Public Health (UKFPH) in March 2014. She was awarded the inaugural Global Public Health Award from the UKFPH in June 2016. She obtained a European Research Council Consolidator grant in November 2017 to carry out a world-wide study on inequalities in survival from cancers of the breast, cervix and ovary.
Claudia was a Research Fellow in Medical Statistics and Epidemiology in Pavia (Italy) from 1998 to 2001. From 2001 to 2011, she worked as a Research Fellow in the Epidemiology Unit, Istituto Nazionale Tumori, Milan (Italy), on EUROCARE (European Cancer Registry-based study of survival and care of cancer patients) and related studies, and on the HAEMACARE project (haematological malignancies). She has been working in the Cancer Survival Group at LSHTM since October 2011.
Claudia is involved in various teaching modules of the MSc Epidemiology and other masters courses, and in the Advanced Course in Epidemiological Analysis. She is a co-organiser of the short course "Cancer Survival: Principles, Methods and Applications". Claudia is also a tutor on the Epidemiology MSc and, from November 2013 to February 2019 has been one of the two Departmental Research Degree Co-ordinators for NCDE.
Claudia’s main interests are in international comparisons of cancer survival, “high-resolution” studies and the estimation of avoidable premature deaths, with a focus on their impact on cancer policy. She has more than 15 years’ experience in this domain. She leads a team of five researchers on data management, quality control and survival analysis for the global surveillance of cancer survival (CONCORD), for which she is co-Principal Investigator. She is also PI of the ERC-funded VENUSCANCER project.